Hyperinsulinemia and insulin resistance, common in individuals with obesity, further elevate cancer risk by increasing circulating insulin-like growth factor 1 (IGF-1), which has mitogenic and anti-apoptotic properties (32–34). This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.